Clinical evaluation of Phenserine tartrate Extended Controlled Release Tablet (ECRT) formulation in early mild Alzheimer’s disease and mild to moderate traumatic brain injury
Award Notice Posted
- Solicitation number
- 75N95022R00041
- Agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Awarded
- to University Of Exeter
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75N95024D00002 Federal IDV award
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Place of performance
- United Kingdom
Notice details come from SAM.gov. Updated .
About this opportunity
This IDIQ contract was awarded to the University of Exeter on January 29, 2024 by the National Institutes of Health National Institute on Drug Abuse. The contract provides for a clinical evaluation of Phenserine tartrate Extended Controlled Release Tablet formulation in early mild Alzheimer's disease and mild to moderate traumatic brain injury, with a minimum order value of $962,486 and maximum order limitation of $1,988,692 over the duration of the contract.
Notice text
Clinical evaluation of Phenserine tartrate Extended Controlled Release Tablet (ECRT) formulation in early mild
Alzheimer's disease and mild to moderate traumatic brain injury.
IDIQ Contract No. 75N95024D00002
IDIQ Contract Award Dollar Amount: $962,486.00 Minimum Order; $1,988,692.00 Maximum Order Limitation
Awarded contract 75N95024D00002 to UNIVERSITY OF EXETER for 1988692.00 on 2024-01-29.
Notice history
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity